Who has invested in Amalgam Rx?

Novo Nordisk, Catalio Capital Management, CVS Health Ventures, Thomas Thestrup Terp are named among the investors backing Amalgam Rx.

Amalgam Rx Funding: $37M Raised, Growth (2025)

Amalgam Rx funding overview

Amalgam Rx is based in Wilmington, Delaware. Amalgam Rx has raised $37M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Growth announced in August 2025. The round record for Amalgam Rx runs through 2025; nothing later has been disclosed. Investors on record include Novo Nordisk, Catalio Capital Management, CVS Health Ventures, Thomas Thestrup Terp. 4 distinct backers are named across the disclosed rounds.

Amalgam Rx at a glance

Total raised: $37M
Latest round: Growth
Latest round date: August 2025
Headquarters: Wilmington, Delaware
Notable investors: Novo Nordisk, Catalio Capital Management, CVS Health Ventures, Thomas Thestrup Terp

Frequently asked about Amalgam Rx funding

How much has Amalgam Rx raised?: Amalgam Rx has raised $37M in total disclosed funding across the rounds on record.
Who has invested in Amalgam Rx?: Novo Nordisk, Catalio Capital Management, CVS Health Ventures, Thomas Thestrup Terp are named among the investors backing Amalgam Rx.
What was the latest Amalgam Rx funding round?: The most recent disclosed round is a Growth, announced in August 2025.
Where is Amalgam Rx based?: Amalgam Rx is based in Wilmington, Delaware.
When did Amalgam Rx last raise?: The last disclosed Amalgam Rx round closed in August 2025 at Growth.

Amalgam Rx totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Wilmington below to benchmark round size and investor mix.

Amalgam Rx Funding: $37M Raised, Growth (2025)

Amalgam Rx funding overview

Amalgam Rx at a glance

Frequently asked about Amalgam Rx funding

Companies related to Amalgam Rx (23)

Browse related funding lists (5)